SCHEMBL2227885

SCHEMBL2227885

Brc1cccc2cc3c(Br)cccc3cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
HIF1A Q16665 2/20 0.43
HSD17B10 Q99714 2/20 0.43
CYP1B1 Q16678 1/20 0.43
SLC9A1 P19634 1/20 0.43
BACE1 P56817 2/20 0.41
AHR P35869 2/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
NOS1 P29475 2/20 0.38
AXL P30530 1/20 0.38
CA12 O43570 1/20 0.37
CA9 Q16790 1/20 0.37
PARP1 P09874 1/20 0.37
CYP2A6 P11509 1/20 0.36
CYP1A2 P05177 2/20 0.36
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
MAOA P21397 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29971666 1.00 ALDH1A1 (0.43) ALDH1A1HIF1AHSD17B10CYP1B1SLC9A1
SCHEMBL29388401 0.92 ALDH1A1 (0.45) ALDH1A1HIF1AHSD17B10CYP1B1SLC9A1
SCHEMBL2407961 0.92 ALDH1A1 (0.45) ALDH1A1HIF1AHSD17B10CYP1B1SLC9A1
SCHEMBL1646342 0.92 SLC9A1 (0.42) ALDH1A1HIF1AHSD17B10CYP1B1SLC9A1
SCHEMBL29420851 0.92 SLC9A1 (0.42) ALDH1A1HIF1AHSD17B10CYP1B1SLC9A1
SCHEMBL30149559 0.90 ALDH1A1 (0.44) ALDH1A1HIF1AHSD17B10CYP1B1SLC9A1
SCHEMBL31364317 0.90 ALDH1A1 (0.44) ALDH1A1HIF1AHSD17B10CYP1B1SLC9A1
SCHEMBL17849090 0.90 ALDH1A1 (0.44) ALDH1A1HIF1AHSD17B10CYP1B1SLC9A1
SCHEMBL17849080 0.90 ALDH1A1 (0.44) ALDH1A1HIF1AHSD17B10CYP1B1SLC9A1
SCHEMBL1873234 0.90 ALDH1A1 (0.44) ALDH1A1HIF1AHSD17B10CYP1B1SLC9A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110797538-B Silicon-based negative electrode binder, preparation method thereof and application thereof in lithium ion battery 湖北亿纬动力有限公司 2021-06-25 CN claimed
CN-111233767-B Anthracene-based dipyrazole compound and preparation method and application thereof 北京工业大学 2021-06-01 CN claimed
CN-111233767-A Anthracene-based dipyrazole compound and preparation method and application thereof 北京工业大学 2020-06-05 CN claimed
CN-110797538-A Silicon-based negative electrode binder, preparation method thereof and application thereof in lithium ion battery 惠州亿纬锂能股份有限公司 2020-02-14 CN claimed
US-7985521-B2 Anthracene containing photoconductors XEROX CORPORATION (US) 2011-07-26 US claimed
US-20090297964-A1 ANTHRACENE CONTAINING PHOTOCONDUCTORS XEROX CORPORATION (US) 2009-12-03 US claimed
US-12471492-B2 Organic compound, light-emitting device, light-emitting apparatus, electronic device, display device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-11-11 US disclosed
CN-116116205-A Method for retarding generation of chloro-and bromo-polycyclic aromatic hydrocarbon by polycyclic aromatic hydrocarbon precursor 国科大杭州高等研究院 2023-05-16 CN disclosed
CN-116082369-A Organic electroluminescent material based on triazolopyridine and organic electroluminescent device 武汉尚赛光电科技有限公司 2023-05-09 CN disclosed
CN-115716798-A Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device 株式会社半导体能源研究所 2023-02-28 CN disclosed
CN-110452689-B Triazolopyridine-based organic electroluminescent material and organic electroluminescent device 武汉尚赛光电科技有限公司 2023-02-28 CN disclosed
CN-111377827-B Alpha-diimine ligand compound, complex and preparation method of polyolefin lubricating oil base oil 辽宁奥克化学股份有限公司 2022-11-25 CN disclosed
CN-107641096-B Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device 株式会社半导体能源研究所 2022-10-21 CN disclosed
US-20090297964-A1 ANTHRACENE CONTAINING PHOTOCONDUCTORS XEROX CORPORATION (US) 2009-12-03 US disclosed
US-20090297964-A1 ANTHRACENE CONTAINING PHOTOCONDUCTORS XEROX CORPORATION (US) 2009-12-03 US disclosed
EP-2115059-A1 FLAME RETARDANT COMPOSITION FOR USE IN STYRENICS CHEMTURA CORPORATION (US) 2009-11-11 EP disclosed
US-20090048413-A1 Method for Production of Conjugated Polymer SUMITOMO CHEMICAL COMPANY, LIMITED 2009-02-19 US disclosed
EP-1997844-A1 METHOD FOR PRODUCTION OF CONJUGATED POLYMER Sumitomo Chemical Company, Limited (JP) 2008-12-03 EP disclosed
WO-2008127753-A1 FLAME RETARDANT COMPOSITION FOR USE IN STYRENICS CHEMTURA CORPORATION (US) 2008-10-23 WO disclosed
US-20080221239-A1 Flame retardant composition for use in styrenics RECREATIONAL WATER PRODUCTS, INC. 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12471492-B2 Organic compound, light-emitting device, light-emitting apparatus, electronic device, display device, and lighting device SUN2, CRY2, NBAS ALDH1A1 229/4885HIF1A 4483/4885HSD17B10 1671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.